V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 200006886 | 200016971 | 1.7 | null | null | null | 2022-01-23 | null | null | null | INTERIM TRIAL | 101514105 |
| 200006887 | 200016972 | 1.6 | null | null | 2017-04-24 | 2017-04-24 | null | 02 | null | IPILIMUMAB | 100279174 |
| 200006905 | 200016979 | null | 93.7 | Palliative (P) | 2018-05-01 | 2018-05-09 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 100679217 |
| 200006909 | 200016980 | null | 79.8 | Palliative (P) | null | 2019-07-22 | null | null | N | TRIAL | 101076497 |
| 200006910 | 200016981 | 1.51 | null | null | null | 2020-08-13 | null | null | null | TRAMETINIB | 100211940 |
| 200006916 | 200016984 | 1.8 | 75.6 | Palliative (P) | 2020-05-10 | 2020-10-27 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 101509721 |
| 200006917 | 200016985 | 1.74 | 89.5 | Palliative (P) | 2020-06-17 | 2020-07-29 | null | null | null | IPILIMUMAB | 100783990 |
| 200006923 | 200016988 | 1.73 | 111 | Palliative (P) | 2020-03-02 | 2020-03-02 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 100668109 |
| 200006925 | 200016989 | null | 46.7 | Palliative (P) | 2020-06-11 | 2020-07-23 | IPILIMUMAB + NIVOLUMAB | 02 | N | IPILIMUMAB + NIVOLUMAB | 100095514 |
| 200006928 | 200016991 | 1.54 | null | null | null | 2014-08-22 | null | null | null | TALIMOGENE LAHERPAREPVEC | 100048208 |
| 200006936 | 200016993 | 0 | null | null | null | 2018-01-30 | null | null | null | DOCETAXEL | 100124330 |
| 200006939 | 200016994 | 1.78 | 94.7 | Palliative (P) | null | 2020-09-10 | null | null | N | TALIMOGENE LAHERPAREPVEC | 101049770 |
| 200006941 | 200016995 | null | null | null | null | 2018-06-30 | null | null | null | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 101061534 |
| 200006945 | 200016998 | null | null | null | null | 2020-05-01 | null | null | null | TRIAL UNSPECIFIED | 101418315 |
| 200006955 | 200017003 | 1.79 | 51.65 | Palliative (P) | 2021-07-15 | 2021-07-15 | IPILIMUMAB + NIVOLUMAB | 02 | N | IPILIMUMAB + NIVOLUMAB | 100712768 |
| 200006962 | 200017005 | 1.78 | null | null | null | 2016-06-19 | null | null | null | BLEOMYCIN | 100059452 |
| 200006968 | 200017008 | 1.47 | 0 | 03 | null | 2020-06-30 | null | null | N | TRIAL UNSPECIFIED | 100723129 |
| 200006970 | 200017009 | 1.8 | 117 | Palliative (P) | null | 2020-07-28 | null | null | N | VEMURAFENIB | 100741381 |
| 200006973 | 200017010 | 1.68 | 65.4 | Palliative (P) | null | 2021-03-13 | null | null | N | IPILIMUMAB + NIVOLUMAB | 100652588 |
| 200006984 | 200017016 | 1.7 | null | null | null | 2018-06-08 | null | null | null | TRIAL UNSPECIFIED | 100536499 |
| 200006986 | 200017017 | null | null | null | null | 2019-02-25 | null | null | null | TRIAL UNSPECIFIED | 100390217 |
| 200006989 | 200017018 | 1.79 | null | null | null | 2018-01-22 | null | null | null | IBRUTINIB | 101839622 |
| 200006990 | 200017019 | 1.7 | 61.7 | Palliative (P) | 2019-06-15 | 2019-09-07 | IPILIMUMAB + NIVOLUMAB | 02 | N | IPILIMUMAB + NIVOLUMAB | 101087573 |
| 200006993 | 200017020 | 1.76 | 81 | Palliative (P) | 2018-06-02 | 2018-06-04 | IPILIMUMAB + NIVOLUMAB | 02 | N | IPILIMUMAB + NIVOLUMAB | 101285267 |
| 200006994 | 200017021 | 1.79 | 74 | null | 2018-01-15 | 2018-01-15 | Bortezomib + MELPHALAN | N | null | IPILIMUMAB + NIVOLUMAB | 101564350 |
| 200000142 | 200017026 | 1.63 | null | null | null | 2020-01-12 | null | null | null | IPILIMUMAB + NIVOLUMAB | 101216639 |
| 200000192 | 200017028 | null | 150.9 | Palliative (P) | 2019-05-08 | 2019-05-09 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 101248170 |
| 200000251 | 200017029 | 1.73 | 88.6 | Adjuvant (A) | null | 2020-04-05 | null | null | N | DOCETAXEL | 101153810 |
| 200000433 | 200017035 | 1.74 | null | null | null | 2018-05-16 | null | null | null | INTERIM TRIAL | 101218305 |
| 200000517 | 200017038 | 1.77 | 104.5 | Palliative (P) | 2018-09-26 | 2018-10-17 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 101567108 |
| 200000521 | 200017039 | 1.73 | 91 | 03 | null | 2017-04-30 | null | null | N | INTERIM TRIAL | 100245605 |
| 200000555 | 200017041 | 1.78 | 94.25 | null | 2021-02-24 | 2021-02-24 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 101143516 |
| 200000642 | 200017044 | null | 78.5 | Palliative (P) | 2017-11-05 | 2017-11-18 | null | 02 | N | DABRAFENIB | 100561144 |
| 200000696 | 200017045 | 1.64 | null | null | null | 2019-07-20 | null | null | null | IPILIMUMAB + NIVOLUMAB | 101298398 |
| 200000832 | 200017046 | 1.76 | 57.7 | Palliative (P) | null | 2020-10-27 | null | null | N | TRAMETINIB | 101526673 |
| 200000932 | 200017047 | 1.76 | 61 | Neo-adjuvant (N) | 2022-02-08 | 2022-03-01 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 101759850 |
| 200001057 | 200017050 | 1.72 | null | null | null | 2018-08-08 | null | null | null | TRIAL UNSPECIFIED | 101759961 |
| 200001141 | 200017051 | null | null | null | null | 2019-06-29 | null | null | null | RITUXIMAB | 101144325 |
| 200001517 | 200017063 | 1.78 | 65.4 | Adjuvant (A) | null | 2019-01-30 | null | null | N | TRIAL UNSPECIFIED | 100774172 |
| 200001637 | 200017064 | null | 75.1 | Palliative (P) | null | 2018-12-25 | null | null | N | TALIMOGENE LAHERPAREPVEC | 100950580 |
| 200001688 | 200017065 | 1.83 | 79 | Palliative (P) | null | 2019-09-20 | null | null | N | COLUMBUS TRIAL | 101146741 |
| 200001858 | 200017069 | null | null | null | null | 2019-12-18 | null | null | null | INTERIM TRIAL | 101241190 |
| 200002188 | 200017074 | 1.76 | null | null | null | 2018-03-18 | null | null | null | TRIAL UNSPECIFIED | 100467259 |
| 200002566 | 200017076 | null | 78.4 | Palliative (P) | 2020-05-13 | 2020-05-23 | IPILIMUMAB + NIVOLUMAB | 02 | N | IPILIMUMAB + NIVOLUMAB | 100731728 |
| 200002664 | 200017077 | 1.7 | 87 | Palliative (P) | 2019-11-01 | 2019-11-01 | null | null | null | INTERIM TRIAL | 100935981 |
| 200002754 | 200017080 | 1.7 | 76.5 | Palliative (P) | 2021-04-02 | 2021-04-04 | IPILIMUMAB + NIVOLUMAB | 02 | N | IPILIMUMAB + NIVOLUMAB | 101691798 |
| 200002762 | 200017081 | null | 68 | Palliative (P) | null | 2019-09-30 | null | null | N | IPILIMUMAB + NIVOLUMAB | 100395546 |
| 200002858 | 200017083 | 1.76 | null | null | null | 2019-03-18 | null | null | null | TALIMOGENE LAHERPAREPVEC | 101853595 |
| 200002941 | 200017085 | null | null | null | null | 2019-08-03 | null | null | null | TRIAL UNSPECIFIED | 100767081 |
| 200003077 | 200017086 | 1.9 | null | null | null | 2021-06-08 | null | null | null | IPILIMUMAB | 101484698 |